We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
+16.56%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$109M
AUM Growth
+$37.7M
Cap. Flow
+$27.4M
Cap. Flow %
25.14%
Top 10 Hldgs %
99.92%
Holding
12
New
1
Increased
–
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
AVDR
Avedro, Inc Common Stock
AVDR
+$34.3M

Top Sells

Rank Stock Value
1
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$6.34M
2
TSRO
TESARO, Inc.
TSRO
+$590K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVDR
1
DELISTED
Avedro, Inc Common Stock
AVDR
$33.6M 30.91%
+2,742,239
New +$34.3M
MGNX icon
2
MacroGenics
MGNX
$254M
$19.3M 17.74%
1,074,316
– –
STIM icon
3
Neuronetics
STIM
$126M
$15.7M 14.44%
1,030,689
– –
KALV
4
DELISTED
KalVista Pharmaceuticals
KALV
$11.1M 10.22%
388,766
– –
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$10.7M 9.87%
25,610
-15,786
-38% -$6.34M
AGTC
6
DELISTED
Applied Genetic Technologies Corporation
AGTC
$6.1M 5.6%
1,455,904
– –
HIND
7
Vyome Holdings
HIND
$14M
– –
0
– –
CDTX
8
DELISTED
Cidara Therapeutics
CDTX
$3.6M 3.3%
67,841
– –
VERO
9
DELISTED
Venus Concept
VERO
$3.16M 2.9%
2,164
– –
GKOS icon
10
Glaukos
GKOS
$8.92B
$263K 0.24%
3,362
– –
XENE icon
11
Xenon Pharmaceuticals
XENE
$6.36B
$84K 0.08%
8,293
– –
TSRO
12
DELISTED
TESARO, Inc.
TSRO
– –
-7,952
Closed -$590K

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q1 2019 Portfolio in Review

As of Q1 2019, InterWest Venture Management held 12 positions worth $109M, up 53% from $71.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

InterWest Venture Management deployed $27.4M of net new capital in Q1 2019, opening 1 new position. Its largest new stake was Avedro, Inc Common Stock: 2,742,239 shares worth $33.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Eiger BioPharmaceuticals, Inc., an estimated $6.34M trimmed.

  • InterWest Venture Management's largest Q1 2019 buy was Avedro, Inc Common Stock: 2,742,239 shares worth $33.6M.
  • InterWest Venture Management's biggest Q1 2019 reduction was Eiger BioPharmaceuticals, Inc., cutting an estimated $6.34M.
  • InterWest Venture Management fully exited TESARO, Inc. in Q1 2019, selling an estimated $590K.
  • InterWest Venture Management's ten largest holdings make up 100% of its $109M portfolio in Q1 2019.
  • InterWest Venture Management opened 1 new position and closed 1 in Q1 2019.
  • InterWest Venture Management's portfolio value rose 53% quarter-over-quarter to $109M.

Based on InterWest Venture Management's 13F filing for Q1 2019, filed 15 Apr 2019.